Share This Page
Drug Price Trends for NDC 62135-0630
✉ Email this page to a colleague
Average Pharmacy Cost for 62135-0630
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| CIMETIDINE 200 MG TABLET | 62135-0630-30 | 0.21821 | EACH | 2025-12-17 |
| CIMETIDINE 200 MG TABLET | 62135-0630-30 | 0.22990 | EACH | 2025-11-19 |
| CIMETIDINE 200 MG TABLET | 62135-0630-30 | 0.24194 | EACH | 2025-10-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 62135-0630
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 62135-0630
Introduction
The drug designated by NDC 62135-0630 is a pharmaceutical product marketed within the United States healthcare system. Understanding its market dynamics and projecting future pricing trends are critical for stakeholders, including manufacturers, healthcare providers, investors, and policymakers. This analysis synthesizes current market data, competitive landscape, regulatory considerations, and economic factors to inform strategic decision-making.
Product Overview
NDC 62135-0630 corresponds to a specific pharmaceutical formulation, likely a prescription medication regulated under the FDA's National Drug Code system. Precise details—such as active ingredient, dosage form, and manufacturer—are essential for an in-depth market analysis but are not provided here. However, for this overview, it is assumed this medication addresses a chronic or acute indication with a significant patient population, typical of drugs within this NDC range.
Market Size and Demand Dynamics
Therapeutic Area and Patient Population
The demand for a drug with NDC 62135-0630 depends heavily on its therapeutic area. If it targets a high-prevalence condition—such as hypertension, diabetes, or cancer—market size could be substantial. According to IQVIA data, chronic condition medications often see stable or growing demand driven by aging populations and increased disease prevalence.
Prevalence Trends
The incidence and prevalence of the underlying condition influence market size. For diseases like diabetes, U.S. prevalence has increased, leading to sustained demand for targeted therapies. Conversely, drugs serving niche markets or orphan indications may experience limited but stable demand.
Competitive Landscape
Market share is subject to competition from existing branded drugs, generics, biosimilars, and new entrants. Patent status influences market exclusivity; generic availability typically erodes prices, whereas brand exclusives sustain higher margins. The expiration of patents or the introduction of biosimilars can significantly alter market dynamics.
Pricing Landscape
Current Pricing
The current wholesale acquisition cost (WAC) or average selling price (ASP) provides a baseline. For brand-name drugs with patent protection, prices tend to be higher, often ranging from hundreds to thousands of dollars per unit, depending on dosage and form. Generic competition reduces prices significantly, sometimes by 80-90%, depending on market penetration.
Pricing Influencers
-
Regulatory and Reimbursement Policies: CMS reimbursement rates, Medicaid, and private insurance negotiations exert downward pressure on prices.
-
Supply Chain Factors: Manufacturing costs, supply chain disruptions, and procurement policies influence prices.
-
Market Access and Payer Coverage: Expanded insurance coverage facilitates higher usage; formulary positioning impacts actual prices paid.
Regulatory and Patent Status
Understanding the patent lifecycle is paramount—patents typically protect drugs for 20 years, with exclusivity periods potentially extended by patent tricks or regulatory incentives. Once patents expire, biosimilar and generic competition usually enters, resulting in price erosion.
Current patent status for NDC 62135-0630 must be verified through FDA’s Orange Book database. The timing of patent expirations impacts the price trajectory significantly.
Price Projection Models
Factors Influencing Future Prices
-
Patent Expiry Timeline: Anticipated patent expiration within 3-5 years usually correlates with a decline in prices due to generic entry.
-
Market Penetration: Increased adoption and formulary inclusion bolster prices temporarily, especially if the drug gains a substantial market share before patent cliff.
-
Regulatory Changes: Policy shifts towards cost containment, importation, or biosimilar promotion could suppress future prices.
-
Innovation and Line Extensions: Next-generation formulations or combination therapies can maintain or elevate prices, extending brand exclusivity.
Projected Pricing Trends
Based on historical patterns of similar drugs:
-
Short-term (1-2 years): Prices will likely remain stable or see slight increases, driven by inflation and market expansion.
-
Mid-term (3-5 years): With patent expiry, expect a decline of 50-80% in wholesale prices due to generic entry. The magnitude depends on competition and market size.
-
Long-term (beyond 5 years): Prices stabilize at generic levels unless new formulations or indications justify higher pricing.
Market Entry and Competitive Strategies
Emerging competitors may introduce biosimilars or generics. Strategic actions include:
-
Patent litigation or extension efforts to delay generic entry.
-
Market differentiation through novel formulations or delivery mechanisms.
-
Pricing strategies like value-based pricing or rebate arrangements to sustain revenue.
Economic and External Factors
-
Inflation and Manufacturing Costs: Rising costs pressure prices, but competitive markets tend to suppress them.
-
Healthcare Policy: Policy initiatives targeting drug affordability could impact pricing strategies.
-
Global Supply Dynamics: Importation policies and international markets affect supply costs and pricing strategies.
Conclusion
The market for NDC 62135-0630 exhibits stability in the near term, with potential for significant price reductions following patent expiration. Stakeholders should monitor patent statuses, competitive launches, and policy shifts to optimize timing for market entry or exit strategies.
Key Takeaways
-
Demand is driven by the therapeutic area and disease prevalence. High-prevalence conditions sustain demand but effectively compete on price.
-
Patent status is the primary determinant of near-term pricing. Patents extending beyond 3-5 years allow for premium pricing; expiration heralds substantial price erosion.
-
Generic and biosimilar entry will significantly impact future prices, with potential declines of up to 80% within 3-5 years post-patent expiry.
-
Market expansion, formulary access, and payer negotiations influence achievable prices throughout a drug's lifecycle.
-
Proactive patent management, innovation, and market differentiation are crucial for maintaining profitability amid evolving competition.
FAQs
-
What is the typical timeframe for patent expiry for drugs similar to NDC 62135-0630?
Many drugs hold patent protection for around 10-12 years from approval; expiration often occurs within 3-5 years, depending on patent extensions and regulatory strategies. -
How does the entry of biosimilars affect pricing?
Biosimilars generally lead to price reductions of 20-35%, but the actual impact depends on market acceptance, interchangeability policies, and manufacturer strategies. -
Are there regulatory incentives to extend the exclusivity of drugs like this?
Yes, platforms such as Orphan Drug Designation, Pediatric Exclusivity, or Patent Term Extensions can prolong market exclusivity, maintaining higher prices. -
What factors make a drug’s price resilient against generic competition?
Factors include complex manufacturing, lack of bioequivalent generics, brand loyalty, and limited alternative therapies. -
How can market analysis assist in strategic decision-making for this drug?
It informs optimal timing for patent strategies, market entry, and exit, as well as pricing adjustments aligned with market and regulatory changes.
References
- IQVIA. (2022). Pharmaceutical Market Data.
- FDA. (2023). Orange Book: Patent and Exclusivity Listings.
- Centers for Medicare & Medicaid Services. (2023). Drug Pricing and Reimbursement Data.
- Deloitte. (2022). Pharmaceutical Patent Strategies and Market Trends.
- BioPharmGuy. (2023). Drug Patent Expiration Calendar.
This comprehensive analysis is intended to support informed strategic decisions concerning NDC 62135-0630 within the evolving U.S. pharmaceutical landscape.
More… ↓
